ABL

Abacus Life and AIMCOR Announce New National Distribution Agreement

Retrieved on: 
måndag, juni 3, 2024

ORLANDO, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a pioneering alternative asset manager specializing in longevity and actuarial technology, announced today a new national distribution relationship with AIMCOR, one of the largest national insurance marketing organizations in the United States.

Key Points: 
  • ORLANDO, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- Abacus Life, Inc. (NASDAQ: ABL) (“Abacus” or the “Company”), a pioneering alternative asset manager specializing in longevity and actuarial technology, announced today a new national distribution relationship with AIMCOR, one of the largest national insurance marketing organizations in the United States.
  • Through their network of 40+ brokerage general agencies, AIMCOR specializes in offering protection and retirement solutions to thousands of financial professionals, institutional clients, and other aligned distribution partners across the country.
  • As part of this new relationship, Abacus will offer their expertise and become a preferred partner for life settlement solutions to AIMCOR’s national network of affiliated member firms.
  • “We’re thrilled to enter into a formal relationship with AIMCOR,” said Abacus Chief Executive Officer Jay Jackson.

Burlington Stores, Inc. Reports First Quarter 2024 Earnings

Retrieved on: 
torsdag, maj 30, 2024

Based on our first quarter performance, we are increasing our margin and earnings guidance for the year.

Key Points: 
  • Based on our first quarter performance, we are increasing our margin and earnings guidance for the year.
  • Diluted weighted average shares outstanding amounted to 64.3 million during the quarter compared with 65.3 million during the first quarter of Fiscal 2023.
  • Reserve inventory was 40% of total inventory at the end of the first quarter of Fiscal 2024 compared to 44% at the end of the first quarter of Fiscal 2023.
  • During the first quarter of Fiscal 2024 the Company repurchased 312,238 shares of its common stock under its share repurchase program for $63 million.

I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024

Retrieved on: 
torsdag, maj 23, 2024

Ragistomig was designed as a bispecific antibody to provide anti-PD-L1 activity and 4-1BB-driven T-cell activation in one molecule.

Key Points: 
  • Ragistomig was designed as a bispecific antibody to provide anti-PD-L1 activity and 4-1BB-driven T-cell activation in one molecule.
  • “We are pleased to present the Phase 1 data to date for ragistomig at ASCO 2024.
  • These data support further development of ragistomig as both a monotherapy and in combination with other compounds.
  • Observation of responses is also encouraging, including a 25% ORR and a 75% clinical benefit rate (CBR), at the optimal dose of 5 mg/kg.

Alta Equipment Group Announces Pricing of Private Offering of $500 Million of Senior Secured Second Lien Notes due 2029

Retrieved on: 
tisdag, maj 21, 2024

The offering of the notes is expected to close on June 5, 2024, subject to customary closing conditions.

Key Points: 
  • The offering of the notes is expected to close on June 5, 2024, subject to customary closing conditions.
  • The notes will be guaranteed by all of the Company’s domestic subsidiaries and will be secured by a second lien on substantially all of the assets of the Company and its subsidiaries.
  • The First Lien Facilities will be secured by a first-priority lien on the same assets securing the notes.
  • This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.

Alta Equipment Group Announces Proposed Private Offering of $500 Million of Senior Secured Second Lien Notes

Retrieved on: 
måndag, maj 20, 2024

The notes will be guaranteed by all of the Company’s domestic subsidiaries and will be secured by a second lien on substantially all of the assets of the Company and its domestic subsidiaries.

Key Points: 
  • The notes will be guaranteed by all of the Company’s domestic subsidiaries and will be secured by a second lien on substantially all of the assets of the Company and its domestic subsidiaries.
  • The First Lien Facilities will be secured by a first-priority lien on the same assets securing the notes.
  • The offering and related refinancing is expected to be leverage neutral for the Company.
  • This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995.

Lifecore Biomedical Completes Incremental Liquidity Initiatives

Retrieved on: 
torsdag, maj 16, 2024

CHASKA, Minn., May 16, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), announced certain incremental liquidity measures and housekeeping matters related to divested businesses through a series of 8-K filings over the past week.

Key Points: 
  • CHASKA, Minn., May 16, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), announced certain incremental liquidity measures and housekeeping matters related to divested businesses through a series of 8-K filings over the past week.
  • James G. Hall, President and Chief Executive Officer of Lifecore, commented, “We believe these incremental liquidity improvements will provide Lifecore with additional financial resources to continue to achieve its business objectives.
  • During fiscal year 2024, and with the approximately $8 million of incremental liquidity improvements recently announced, we have now added up to approximately $18.5 million in non-dilutive incremental liquidity.
  • Giving effect to the incremental liquidity increases announced today, on a pro forma basis, total debt and cash as of April 21, 2024 would have been $178.9 million and $11.0 million, respectively.

Vallourec First Quarter 2024 Results

Retrieved on: 
torsdag, maj 16, 2024

In Q1 2024, Vallourec recorded revenues of €990 million, down (26%) year over year, which was also (26%) at constant exchange rates.

Key Points: 
  • In Q1 2024, Vallourec recorded revenues of €990 million, down (26%) year over year, which was also (26%) at constant exchange rates.
  • Net interest expense in Q1 2024 was (€15) million compared to (€26) million in Q1 2023.
  • Mine & Forest: In Q1 2024, iron ore production sold was 1.4 million tonnes, decreasing by 9% year over year.
  • In the second quarter of 2024, based on our assumptions and current market conditions, Vallourec expects:
    Group EBITDA to moderately decline versus Q1 due to US Tubes market dynamics:
    For the full year 2024, based on our assumptions and current market conditions, Vallourec expects:
    Group EBITDA margin to remain strong through 2024, driven by:
    Continued strong performance in Tubes, due to robust international Tubes pricing in backlog and further operational improvement
    This press release includes forward-looking statements.

Staples, Inc. Announces Early Exchange Results of Exchange Offer for Outstanding 10.75% Senior Notes due 2027 and Consent Solicitation and Changes to the Late Exchange Consideration

Retrieved on: 
torsdag, maj 23, 2024

Such CUSIP numbers and ISINs are provided solely for the convenience of the Eligible Holders of Old Notes.

Key Points: 
  • Such CUSIP numbers and ISINs are provided solely for the convenience of the Eligible Holders of Old Notes.
  • The Early Exchange Consideration and the Late Exchange Consideration, as applicable, will be paid on the Settlement Date.
  • The Exchange Notes will only be issued in minimum principal denominations of $2,000 and integral multiples of $1.00 in excess thereof.
  • King & Co., Inc. has been appointed as the exchange agent and information agent for the Exchange Offer and Consent Solicitation.

Wallbox Announces Six Month Milestones in The Acquisition of ABL, A German Leader in EV Charging

Retrieved on: 
onsdag, maj 22, 2024

Wallbox, a global leader in electric vehicle (EV) charging and energy management solutions, announced a number of key strategic milestones since their acquisition of ABL, an industry pioneer and German leader in EV charging.

Key Points: 
  • Wallbox, a global leader in electric vehicle (EV) charging and energy management solutions, announced a number of key strategic milestones since their acquisition of ABL, an industry pioneer and German leader in EV charging.
  • The integration of ABL into the Wallbox Group has already yielded encouraging results that will strengthen both companies' ability to support the EV transition.
  • Co-development of a fast charging solution: ABL and Wallbox plan to launch a Supernova fast charger for public application in the German market.
  • The integration of ABL into the Wallbox Group is another example of effective and continuous consolidations within the EV charging industry.

Prime Healthcare Services, Inc. Receives Double Upgrade of Credit and Outlook from Fitch Ratings

Retrieved on: 
onsdag, maj 15, 2024

Prime Healthcare today announces that Fitch Ratings has upgraded Prime Healthcare Services, Inc.’s (PHSI) senior secured notes to “B+” and upgraded the outlook to Stable.

Key Points: 
  • Prime Healthcare today announces that Fitch Ratings has upgraded Prime Healthcare Services, Inc.’s (PHSI) senior secured notes to “B+” and upgraded the outlook to Stable.
  • Fitch noted in their ratings action that the upgrade reflected the improved collateralization stemming from PHSI’s repurchase of 17 previously leased hospitals over the past two years.
  • In April 2024, Fitch Ratings upgraded Prime Healthcare Foundation's Issuer Rating and the Revenue Bond Credit rating to BBB+ while rating the Outlook as Stable for its 14 not-for-profit hospitals in six states.
  • The credit rating upgrade by Fitch was the second credit rating upgrade given by the rating agency to PHF in the last three years.